Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. scores highest on Torque (58) and lowest on Nitro (19). Its PosiPenta is 36.08 out of 100, weaker than most similar companies.
On the Penta Grid this week, Lexeo Therapeutics, Inc. is Grid #644 of 837 in the Healthcare sector in United States, and Grid #3,211 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. | 36.08 | 40 | 31 | 19 | 58 | 32 |
| Zentalis Pharmaceuticals, Inc. | 37.12 | 34 | 30 | 35 | 39 | 47 |
| Utah Medical Products, Inc. | 79.49 | 58 | 90 | 95 | 82 | 72 |
| Larimar Therapeutics, Inc. | 37.40 | 32 | 44 | 24 | 42 | 46 |
| Palisade Bio, Inc. | 52.20 | 74 | 43 | 39 | 66 | 40 |
| American Well Corporation | 54.33 | 40 | 40 | 85 | 67 | 39 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.59 |
| P/B ratio | 0.92 |
EEarnings
| Trailing EPS | ₹-96.61 |
| Forward EPS | ₹-129.22 |
NNitro
| Price | 250.05 |
| 52-week high | 1040.92 |
| 52-week low | 242.47 |
| Fall from 52-week high | 76.0% |
TTorque
| Return on equity (ROE) | -46.76% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | 1.64 |
| Market cap | ₹2,052 Cr |
| Insider holding | 0.64% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Lexeo Therapeutics, Inc.'s PosiPenta score?
Lexeo Therapeutics, Inc.'s PosiPenta is 36.08 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Lexeo Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Lexeo Therapeutics, Inc. is Grid #644 of 837 in the Healthcare sector in United States, and Grid #3,211 of 4,000 in United States.
Which PosiPenta pillar is strongest for Lexeo Therapeutics, Inc.?
Torque (durability), with a score of 58 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Lexeo Therapeutics, Inc.?
Nitro (momentum), with a score of 19 out of 100: much weaker than most similar companies.
Has Lexeo Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.60 points, from 32.48 to 36.08.
PositoAI is for research and education only and is not investment advice.